BMJ Paediatrics Open (Oct 2018)

Consent and recruitment: the reporting of paediatric trials published in 2012

  • Allison Gates,
  • Patrina Caldwell,
  • Sarah Curtis,
  • Leonila Dans,
  • Ricardo M Fernandes,
  • Lisa Hartling,
  • Lauren E Kelly,
  • Katrina Williams,
  • Kerry Woolfall,
  • Michele P Dyson

DOI
https://doi.org/10.1136/bmjpo-2018-000369
Journal volume & issue
Vol. 2, no. 1

Abstract

Read online

Objectives We evaluated 300 paediatric trials to determine: the consent and recruitment strategies used, who trial information was targeted to, how incentives were used and if they achieved their recruitment targets.Methods For this cross-sectional evaluation, we searched the Cochrane Central Register of Controlled Trials for paediatric trials published in 2012 and randomly selected 300 that reported on outcomes for participants aged ≤21 years. We collected data on consent and recruitment procedures for each trial and undertook descriptive analyses in SPSS statistics V.23.Results All but one trial (99.7%) used a standard recruitment strategy. Most (92%) trials reported that consent was obtained but only 13% reported who obtained consent. Two-thirds (65%) of trials included school-aged participants, and of these 68% reported obtaining assent. Half (50%) of the trials reported who the trial information was targeted to. Most trials (75%) of school-aged participants targeted information towards children or children and their parents. Fourteen per cent of trials reported using incentives, half (50%) of which were in the form of compensation. Only 48% of trials reported sufficient data to determine if their recruitment targets were achieved. Of these, 70% achieved their targets.Conclusions Notable reporting shortcomings included: how families were recruited into the trial, who obtained consent and/or assent and how, who trial information was directed to, whether incentives were used and sufficient data to determine if the recruitment target was achieved. Forthcoming paediatric-specific reporting standards may improve reporting in this priority area. Our data provide a baseline for ongoing monitoring of the state of the research.